 | • レポートコード：MRC2312MG02230 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のペプチドCDMOサービス市場規模と予測を収録しています。・世界のペプチドCDMOサービス市場：売上、2018年-2023年、2024年-2029年 ・世界のペプチドCDMOサービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のペプチドCDMOサービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「低分子CDMO」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ペプチドCDMOサービスのグローバル主要企業は、Incyte、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Jiuzhou Pharmaceutical、 Sinopep、 Frontier Biotechnologies、 JYMed、 Chengdu Shengnuo Biotechnology、 Shanghai Soho-Yiming Pharmaceuticals、 Chinese Peptide Company、 Ambio Pharmaceuticals、 Zhejiang Peptites Biotech、 STA Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ペプチドCDMOサービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のペプチドCDMOサービス市場：タイプ別、2018年-2023年、2024年-2029年 世界のペプチドCDMOサービス市場：タイプ別市場シェア、2022年 ・低分子CDMO、高分子CDMO 世界のペプチドCDMOサービス市場：用途別、2018年-2023年、2024年-2029年 世界のペプチドCDMOサービス市場：用途別市場シェア、2022年 ・臨床治療、医学研究、商業生産 世界のペプチドCDMOサービス市場：地域・国別、2018年-2023年、2024年-2029年 世界のペプチドCDMOサービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるペプチドCDMOサービスのグローバル売上、2018年-2023年 ・主要企業におけるペプチドCDMOサービスのグローバル売上シェア、2022年 ・主要企業におけるペプチドCDMOサービスのグローバル販売量、2018年-2023年 ・主要企業におけるペプチドCDMOサービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Incyte、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Jiuzhou Pharmaceutical、 Sinopep、 Frontier Biotechnologies、 JYMed、 Chengdu Shengnuo Biotechnology、 Shanghai Soho-Yiming Pharmaceuticals、 Chinese Peptide Company、 Ambio Pharmaceuticals、 Zhejiang Peptites Biotech、 STA Pharmaceutical ************************************************************* ・調査・分析レポートの概要 ペプチドCDMOサービス市場の定義 市場セグメント 世界のペプチドCDMOサービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のペプチドCDMOサービス市場規模 世界のペプチドCDMOサービス市場規模：2022年 VS 2029年 世界のペプチドCDMOサービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのペプチドCDMOサービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のペプチドCDMOサービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：低分子CDMO、高分子CDMO ペプチドCDMOサービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：臨床治療、医学研究、商業生産 ペプチドCDMOサービスの用途別グローバル売上・予測 ・地域別市場分析 地域別ペプチドCDMOサービス市場規模 2022年と2029年 地域別ペプチドCDMOサービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Incyte、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Jiuzhou Pharmaceutical、 Sinopep、 Frontier Biotechnologies、 JYMed、 Chengdu Shengnuo Biotechnology、 Shanghai Soho-Yiming Pharmaceuticals、 Chinese Peptide Company、 Ambio Pharmaceuticals、 Zhejiang Peptites Biotech、 STA Pharmaceutical ... |
This research report provides a comprehensive analysis of the Peptide CDMO Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Peptide CDMO Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Peptide CDMO Services, challenges faced by the industry, and potential opportunities for market players.
The global Peptide CDMO Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Peptide CDMO Services market presents opportunities for various stakeholders, including Clinical Treatment, Medical Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Peptide CDMO Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global Peptide CDMO Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Peptide CDMO services usually cover the following aspects: peptide synthesis, process development, quality control, scale production, injection preparation. By choosing peptide CDMO services, the development and manufacture of peptide drugs can be handed over to professional institutions, thereby saving time, reducing costs, and ensuring product quality and compliance.
Key Features:
The research report on the Peptide CDMO Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Peptide CDMO Services market.
Market Overview: The report provides a comprehensive overview of the Peptide CDMO Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small Molecule CDMO, Macro-molecular CDMO), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Peptide CDMO Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Peptide CDMO Services market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Peptide CDMO Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Peptide CDMO Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Peptide CDMO Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Peptide CDMO Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Peptide CDMO Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Peptide CDMO Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Peptide CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small Molecule CDMO
Macro-molecular CDMO
Market segment by Application
Clinical Treatment
Medical Research
Commercial Production
Global Peptide CDMO Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Incyte
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide CDMO Services, market overview.
Chapter 2: Global Peptide CDMO Services market size in revenue.
Chapter 3: Detailed analysis of Peptide CDMO Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide CDMO Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Peptide CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide CDMO Services Overall Market Size
2.1 Global Peptide CDMO Services Market Size: 2022 VS 2029
2.2 Global Peptide CDMO Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide CDMO Services Players in Global Market
3.2 Top Global Peptide CDMO Services Companies Ranked by Revenue
3.3 Global Peptide CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Peptide CDMO Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptide CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Peptide CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Peptide CDMO Services Market Size Markets, 2022 & 2029
4.1.2 Small Molecule CDMO
4.1.3 Macro-molecular CDMO
4.2 By Type – Global Peptide CDMO Services Revenue & Forecasts
4.2.1 By Type – Global Peptide CDMO Services Revenue, 2018-2023
4.2.2 By Type – Global Peptide CDMO Services Revenue, 2024-2029
4.2.3 By Type – Global Peptide CDMO Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Peptide CDMO Services Market Size, 2022 & 2029
5.1.2 Clinical Treatment
5.1.3 Medical Research
5.1.4 Commercial Production
5.2 By Application – Global Peptide CDMO Services Revenue & Forecasts
5.2.1 By Application – Global Peptide CDMO Services Revenue, 2018-2023
5.2.2 By Application – Global Peptide CDMO Services Revenue, 2024-2029
5.2.3 By Application – Global Peptide CDMO Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Peptide CDMO Services Market Size, 2022 & 2029
6.2 By Region – Global Peptide CDMO Services Revenue & Forecasts
6.2.1 By Region – Global Peptide CDMO Services Revenue, 2018-2023
6.2.2 By Region – Global Peptide CDMO Services Revenue, 2024-2029
6.2.3 By Region – Global Peptide CDMO Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Peptide CDMO Services Revenue, 2018-2029
6.3.2 US Peptide CDMO Services Market Size, 2018-2029
6.3.3 Canada Peptide CDMO Services Market Size, 2018-2029
6.3.4 Mexico Peptide CDMO Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Peptide CDMO Services Revenue, 2018-2029
6.4.2 Germany Peptide CDMO Services Market Size, 2018-2029
6.4.3 France Peptide CDMO Services Market Size, 2018-2029
6.4.4 U.K. Peptide CDMO Services Market Size, 2018-2029
6.4.5 Italy Peptide CDMO Services Market Size, 2018-2029
6.4.6 Russia Peptide CDMO Services Market Size, 2018-2029
6.4.7 Nordic Countries Peptide CDMO Services Market Size, 2018-2029
6.4.8 Benelux Peptide CDMO Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Peptide CDMO Services Revenue, 2018-2029
6.5.2 China Peptide CDMO Services Market Size, 2018-2029
6.5.3 Japan Peptide CDMO Services Market Size, 2018-2029
6.5.4 South Korea Peptide CDMO Services Market Size, 2018-2029
6.5.5 Southeast Asia Peptide CDMO Services Market Size, 2018-2029
6.5.6 India Peptide CDMO Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Peptide CDMO Services Revenue, 2018-2029
6.6.2 Brazil Peptide CDMO Services Market Size, 2018-2029
6.6.3 Argentina Peptide CDMO Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Peptide CDMO Services Revenue, 2018-2029
6.7.2 Turkey Peptide CDMO Services Market Size, 2018-2029
6.7.3 Israel Peptide CDMO Services Market Size, 2018-2029
6.7.4 Saudi Arabia Peptide CDMO Services Market Size, 2018-2029
6.7.5 UAE Peptide CDMO Services Market Size, 2018-2029
7 Peptide CDMO Services Companies Profiles
7.1 Incyte
7.1.1 Incyte Company Summary
7.1.2 Incyte Business Overview
7.1.3 Incyte Peptide CDMO Services Major Product Offerings
7.1.4 Incyte Peptide CDMO Services Revenue in Global Market (2018-2023)
7.1.5 Incyte Key News & Latest Developments
7.2 Gliead
7.2.1 Gliead Company Summary
7.2.2 Gliead Business Overview
7.2.3 Gliead Peptide CDMO Services Major Product Offerings
7.2.4 Gliead Peptide CDMO Services Revenue in Global Market (2018-2023)
7.2.5 Gliead Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Peptide CDMO Services Major Product Offerings
7.3.4 Boehringer Ingelheim Peptide CDMO Services Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Vertex
7.4.1 Vertex Company Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex Peptide CDMO Services Major Product Offerings
7.4.4 Vertex Peptide CDMO Services Revenue in Global Market (2018-2023)
7.4.5 Vertex Key News & Latest Developments
7.5 Mirati Therapeutics
7.5.1 Mirati Therapeutics Company Summary
7.5.2 Mirati Therapeutics Business Overview
7.5.3 Mirati Therapeutics Peptide CDMO Services Major Product Offerings
7.5.4 Mirati Therapeutics Peptide CDMO Services Revenue in Global Market (2018-2023)
7.5.5 Mirati Therapeutics Key News & Latest Developments
7.6 AMPAC
7.6.1 AMPAC Company Summary
7.6.2 AMPAC Business Overview
7.6.3 AMPAC Peptide CDMO Services Major Product Offerings
7.6.4 AMPAC Peptide CDMO Services Revenue in Global Market (2018-2023)
7.6.5 AMPAC Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Peptide CDMO Services Major Product Offerings
7.7.4 Pfizer Peptide CDMO Services Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Polypeptide
7.8.1 Polypeptide Company Summary
7.8.2 Polypeptide Business Overview
7.8.3 Polypeptide Peptide CDMO Services Major Product Offerings
7.8.4 Polypeptide Peptide CDMO Services Revenue in Global Market (2018-2023)
7.8.5 Polypeptide Key News & Latest Developments
7.9 Bachem
7.9.1 Bachem Company Summary
7.9.2 Bachem Business Overview
7.9.3 Bachem Peptide CDMO Services Major Product Offerings
7.9.4 Bachem Peptide CDMO Services Revenue in Global Market (2018-2023)
7.9.5 Bachem Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Peptide CDMO Services Major Product Offerings
7.10.4 Merck Peptide CDMO Services Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Asymchem
7.11.1 Asymchem Company Summary
7.11.2 Asymchem Business Overview
7.11.3 Asymchem Peptide CDMO Services Major Product Offerings
7.11.4 Asymchem Peptide CDMO Services Revenue in Global Market (2018-2023)
7.11.5 Asymchem Key News & Latest Developments
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Company Summary
7.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.12.3 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Major Product Offerings
7.12.4 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue in Global Market (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
7.13 Sinopep
7.13.1 Sinopep Company Summary
7.13.2 Sinopep Business Overview
7.13.3 Sinopep Peptide CDMO Services Major Product Offerings
7.13.4 Sinopep Peptide CDMO Services Revenue in Global Market (2018-2023)
7.13.5 Sinopep Key News & Latest Developments
7.14 Frontier Biotechnologies
7.14.1 Frontier Biotechnologies Company Summary
7.14.2 Frontier Biotechnologies Business Overview
7.14.3 Frontier Biotechnologies Peptide CDMO Services Major Product Offerings
7.14.4 Frontier Biotechnologies Peptide CDMO Services Revenue in Global Market (2018-2023)
7.14.5 Frontier Biotechnologies Key News & Latest Developments
7.15 JYMed
7.15.1 JYMed Company Summary
7.15.2 JYMed Business Overview
7.15.3 JYMed Peptide CDMO Services Major Product Offerings
7.15.4 JYMed Peptide CDMO Services Revenue in Global Market (2018-2023)
7.15.5 JYMed Key News & Latest Developments
7.16 Chengdu Shengnuo Biotechnology
7.16.1 Chengdu Shengnuo Biotechnology Company Summary
7.16.2 Chengdu Shengnuo Biotechnology Business Overview
7.16.3 Chengdu Shengnuo Biotechnology Peptide CDMO Services Major Product Offerings
7.16.4 Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue in Global Market (2018-2023)
7.16.5 Chengdu Shengnuo Biotechnology Key News & Latest Developments
7.17 Shanghai Soho-Yiming Pharmaceuticals
7.17.1 Shanghai Soho-Yiming Pharmaceuticals Company Summary
7.17.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
7.17.3 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Major Product Offerings
7.17.4 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue in Global Market (2018-2023)
7.17.5 Shanghai Soho-Yiming Pharmaceuticals Key News & Latest Developments
7.18 Chinese Peptide Company
7.18.1 Chinese Peptide Company Company Summary
7.18.2 Chinese Peptide Company Business Overview
7.18.3 Chinese Peptide Company Peptide CDMO Services Major Product Offerings
7.18.4 Chinese Peptide Company Peptide CDMO Services Revenue in Global Market (2018-2023)
7.18.5 Chinese Peptide Company Key News & Latest Developments
7.19 Ambio Pharmaceuticals
7.19.1 Ambio Pharmaceuticals Company Summary
7.19.2 Ambio Pharmaceuticals Business Overview
7.19.3 Ambio Pharmaceuticals Peptide CDMO Services Major Product Offerings
7.19.4 Ambio Pharmaceuticals Peptide CDMO Services Revenue in Global Market (2018-2023)
7.19.5 Ambio Pharmaceuticals Key News & Latest Developments
7.20 Zhejiang Peptites Biotech
7.20.1 Zhejiang Peptites Biotech Company Summary
7.20.2 Zhejiang Peptites Biotech Business Overview
7.20.3 Zhejiang Peptites Biotech Peptide CDMO Services Major Product Offerings
7.20.4 Zhejiang Peptites Biotech Peptide CDMO Services Revenue in Global Market (2018-2023)
7.20.5 Zhejiang Peptites Biotech Key News & Latest Developments
7.21 STA Pharmaceutical
7.21.1 STA Pharmaceutical Company Summary
7.21.2 STA Pharmaceutical Business Overview
7.21.3 STA Pharmaceutical Peptide CDMO Services Major Product Offerings
7.21.4 STA Pharmaceutical Peptide CDMO Services Revenue in Global Market (2018-2023)
7.21.5 STA Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
